VEGFA and cancer: Recent studies have indicated that the usage VEGF antagonists can protect kidneys of most diabetic rodents (104, 107), while for cancer patients and some non-diabetic nephropathy rodents, if they receive anti-VEGF treatment, their kidneys will potentially be damaged (108).